(Q35148060)

English

Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone®) administered by intradermal and intramuscular route in healthy adults

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

6 August 2017

Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone®) administered by intradermal and intramuscular route in healthy adults (English)

1 reference

Europe PubMed Central

6 August 2017

1 reference

based on heuristic

inferred from title

influenza vaccine

1 reference

based on heuristic

inferred from title

Patricia L Winokur

object named as

Patricia L Winokur

4

0 references

Kathryn M. Edwards

11

object named as

Kathryn M Edwards

1 reference

Europe PubMed Central

6 August 2017

Robert B Belshe

2

object named as

Robert Belshe

1 reference

Europe PubMed Central

6 August 2017

12

object named as

Heather Hill

1 reference

Europe PubMed Central

6 August 2017

Cornelia L. Dekker

8

object named as

Cornelia L Dekker

1 reference

Europe PubMed Central

6 August 2017

author name string

Robert W Frenck

1

1 reference

Europe PubMed Central

6 August 2017

Rebecca C Brady

3

1 reference

Europe PubMed Central

6 August 2017

James D Campbell

5

1 reference

Europe PubMed Central

6 August 2017

John Treanor

6

1 reference

Europe PubMed Central

6 August 2017

Christine M Hay

7

1 reference

Europe PubMed Central

6 August 2017

Emmanuel B Walter

9

1 reference

Europe PubMed Central

6 August 2017

Thomas R Cate

10

1 reference

Europe PubMed Central

6 August 2017

Mark Wolff

13

1 reference

Europe PubMed Central

6 August 2017

Tom Leduc

14

1 reference

Europe PubMed Central

6 August 2017

Nadia Tornieporth

15

1 reference

Europe PubMed Central

6 August 2017

language of work or name

0 references

publication date

23 June 2011

1 reference

Europe PubMed Central

6 August 2017

1 reference

Europe PubMed Central

6 August 2017

29

1 reference

Europe PubMed Central

6 August 2017

34

1 reference

Europe PubMed Central

6 August 2017

5666-5674

1 reference

Europe PubMed Central

6 August 2017

Intradermal influenza vaccination of healthy adults using a new microinjection system: a 3-year randomised controlled safety and immunogenicity trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3150501

28 July 2018

Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3150501

28 July 2018

Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3150501

28 July 2018

Preclinical Evaluation of Microneedle Technology for Intradermal Delivery of Influenza Vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3150501

28 July 2018

Epidermal powder immunization induces both cytotoxic T-lymphocyte and antibody responses to protein antigens of influenza and hepatitis B viruses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3150501

28 July 2018

Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3150501

27 September 2018

Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3150501

27 September 2018

Experiences with obtaining influenza vaccination among persons in priority groups during a vaccine shortage--United States, October-November, 2004.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3150501

27 September 2018

Evaluation of a single dose of half strength inactivated influenza vaccine in healthy adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3150501

27 September 2018

Impact of the 2004-2005 influenza vaccine shortage on pediatric practice: a national survey

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.010

7 January 2021

Influenza vaccine shortage hits the USA

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.010

7 January 2021

CDC expects early-season shortage of influenza vaccine. Supply chain should plan for delays

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.010

7 January 2021

Comparison of influenza serological techniques by international collaborative study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.010

7 January 2021

The visual analogue pain intensity scale: what is moderate pain in millimetres?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.010

7 January 2021

Dose sparing with intradermal injection of influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.010

7 January 2021

Serum antibody responses after intradermal vaccination against influenza

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.010

7 January 2021

Effectiveness of half-dose versus full-dose influenza vaccine in health care workers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.010

7 January 2021

Advances in vaccine delivery: transcutaneous immunisation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.010

7 January 2021

Immunogenicity, large scale safety and lot consistency of an intradermal influenza vaccine in adults aged 18-60 years: Randomized, controlled, phase III trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.010

7 January 2021

Intradermal influenza vaccine for older adults: a randomized controlled multicenter phase III study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.010

7 January 2021

Identifiers

10.1016/J.VACCINE.2011.06.010

1 reference

Europe PubMed Central

6 August 2017

1 reference

Europe PubMed Central

6 August 2017

1 reference

Europe PubMed Central

6 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35148060&oldid=1915124177"